Mediterrania Capital Partners, a private equity firm focused on growth investments for SMEs and mid-cap companies in Africa, announced its acquisition of a stake in Laprophan – a pharmaceutical company in Morocco – through its fund MC IV, alongside DEG, Proparco and FMO.